Havn Life Sciences Inc. (5NP0)

Overview

HAVN Life Sciences Inc. is a pioneering biotechnology company that has carved a niche for itself in the field of psychopharmacological research and development. Established in 2020 and based in Richmond, Canada, the company is focused on harnessing the therapeutic potentials of plants and fungi. With a keen interest in psychoactive compounds, HAVN Life Sciences aims to advance the understanding and accessibility of these substances through rigorous scientific methodologies. Their efforts are directed towards the standardized and quality-controlled extraction of key psychoactive compounds, primarily from Psilocybe spp. mushrooms, among other sources. This innovative approach not only underscores their commitment to scientific excellence but also positions them at the forefront of a burgeoning industry that seeks to explore alternative medicinal pathways.

Products and Services

• Psychoactive Compound Extraction:

  HAVN Life Sciences specializes in the extraction of psychoactive compounds from natural sources, particularly Psilocybe spp. mushrooms. Through meticulous research and development processes, the company strives to achieve standardization and quality control in the extraction of psilocybin, psilocin, and baeocystin. This endeavor aims to unlock the potential therapeutic applications of these compounds in various psychological and neurological conditions.

• Natural Health Care Products:

  In addition to its focus on regulated psychoactive compounds, HAVN Life Sciences is also dedicated to the development of natural healthcare products derived from non-regulated compounds. Leveraging the rich biodiversity of plants and fungi, the company explores the vast potential of these natural sources to offer alternative health solutions. This initiative reflects HAVN Life Sciences’ commitment to expanding the realms of natural healthcare, providing consumers with innovative and holistic wellness options.